APA (7th ed.) Citation

JH, F., JS, S., & LS, E. (2025). Maternal RSVpreF Vaccine: A Novel Agent for Respiratory Syncytial Virus Prevention in Infants. The Annals of pharmacotherapy, 59(8), 758. https://doi.org/10.1177/10600280241302775

Chicago Style (17th ed.) Citation

JH, Fly, Stultz JS, and Eiland LS. "Maternal RSVpreF Vaccine: A Novel Agent for Respiratory Syncytial Virus Prevention in Infants." The Annals of Pharmacotherapy 59, no. 8 (2025): 758. https://doi.org/10.1177/10600280241302775.

MLA (9th ed.) Citation

JH, Fly, et al. "Maternal RSVpreF Vaccine: A Novel Agent for Respiratory Syncytial Virus Prevention in Infants." The Annals of Pharmacotherapy, vol. 59, no. 8, 2025, p. 758, https://doi.org/10.1177/10600280241302775.